How many insider trades does FilingIQ track for CTTH?

FilingIQ tracks 52 Form 4 insider transactions for CTTH (CTT PHARMACEUTICAL HOLDINGS, INC.), covering filings from Feb 18, 2022 onwards. 4 of those were filed in the last 90 days.

Are CTTH insiders net buyers or net sellers?

Across the full Form 4 history for CTTH, 47 transactions (90%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CTTH insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CTTH in?

CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $4.40M.

CTTH insider trading

OTC Markets OTCQB Healthcare

CTT PHARMACEUTICAL HOLDINGS, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

90% / 0%

Market cap

$4.40M

About CTT PHARMACEUTICAL HOLDINGS, INC.

CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida.

Company website: www.cttpharmaceuticals.com

CTTH insider activity at a glance

FilingIQ has scored 52 insider transactions for CTTH since Feb 18, 2022. The most recent filing in our index is dated Aug 20, 2026.

Across the full history, 47 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CTTH insider trades is 57.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CTTH trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 983

UNITED THERAPEUTICS Corp

NUVL 195

Nuvalent, Inc.

KYMR 193

Kymera Therapeutics, Inc.

GH 192

Guardant Health, Inc.

Hims & Hers Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for CTTH?: FilingIQ tracks 52 Form 4 insider transactions for CTTH (CTT PHARMACEUTICAL HOLDINGS, INC.), covering filings from Feb 18, 2022 onwards. 4 of those were filed in the last 90 days.
Are CTTH insiders net buyers or net sellers?: Across the full Form 4 history for CTTH, 47 transactions (90%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CTTH insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CTTH in?: CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $4.40M.

Methodology & sources

Every CTTH insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.